Made in China

October 22, 2020

The FDA approves Remdesivir as the first COVID-19 drug after 3 randomized trials found that it decreased the length of hospital stays. However, the WHO found that it had little or no effect on patients.
AstraZeneca and Johnson & Johnson announce their plants of restarting COVID-19 vaccine trials, which they previously paused.

2020十月二十二日

美国食品和药物管理局在3项随机试验发现雷米司韦缩短了住院时间后，批准其为第一种新冠肺炎药物。然而，世界卫生组织发现它对患者几乎没有影响。
阿斯利康和强生宣布他们的工厂将重新开始COVID-19疫苗试验，此前他们暂停了试验。

While some are hopeful of the COVID-19 vaccine research and discoveries, there are still many that are extremely skeptical.

尽管有些人对新冠肺炎疫苗的研究和发现抱有希望，但仍有许多人持极端怀疑态度。

And what about liability? Has Pfizer been given immunity?

There’s a funny smell around here.
— Alistair Nicholls (@AlistairNic) December 2, 2020

can you elaborate? is the idea that this vaccine is some kind of mind controlling device, designed to turn us into sheeple?
— Steven Minto (@sgrrrd) December 2, 2020

Congratulations Mr Hancock. In terms of deciding who gets priority, please ignore the usual calls for NHS staff or the elderly to receive it first. The health of CEOs and senior business figures is vital to the nation. Therefore, they should be given priority.
— Outspoken CEO (@CeoOutspoken) December 2, 2020

Back